Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00740870 · ClinicalTrials.gov registry record · NA
Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort
A NA study, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- NA
- Development phase
- 171
- Enrollment target
NCT00740870 is a NA study that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 171 participants.
The verdict
NCT00740870, a NA study, has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
Study Summary
The primary objective is to confirm the long-term functionality of implantation of the Medtronic Melody TPV at 5 years is no worse than the historical control established through literature review. The secondary objectives are to evaluate long-term functionality at 10 years and to assess safety, procedural success, and clinical utility of transcatheter implantation of the Melody TPV.
Interventions
- DEVICE Transcatheter Pulmonary Valve replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2007-01 |
| Est. Completion | 2020-08-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00740870
The ClinicalTrials.gov registry entry for NCT00740870 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcatheter Pulmonary Valve replacement is the first listed.
NCT00740870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00740870 about?
NCT00740870 is a clinical study titled "Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort". The primary objective is to confirm the long-term functionality of implantation of the Medtronic Melody TPV at 5 years is no worse than the historical control established through literature review. The secondary objectives are to evaluate long-term functionality at 10 years and to assess safety, pro...
What is the current status of trial NCT00740870?
This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2007-01. Estimated completion is 2020-08-21.
What interventions are being tested in trial NCT00740870?
The interventions under investigation include: Transcatheter Pulmonary Valve replacement (DEVICE).
Who is sponsoring clinical trial NCT00740870?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.